2 215

Cited 46 times in

Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma

DC FieldValueLanguage
dc.contributor.author최진영-
dc.contributor.author김도영-
dc.contributor.author한광협-
dc.contributor.author김범경-
dc.contributor.author김승업-
dc.contributor.author류한작-
dc.contributor.author박준용-
dc.contributor.author안상훈-
dc.contributor.author이도연-
dc.contributor.author전재윤-
dc.date.accessioned2014-12-19T16:22:07Z-
dc.date.available2014-12-19T16:22:07Z-
dc.date.issued2012-
dc.identifier.issn0269-2813-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/89395-
dc.description.abstractBACKGROUND: It remains unclear whether initial compact lipiodol uptake after transarterial chemoembolisation (TACE) is associated with improved survival in patients with hepatocellular carcinoma (HCC). AIM: To reveal the clinical relevance of compact lipiodolisation after TACE. METHODS: We studied 490 patients with unresectable HCC who had first been treated with TACE. Compact lipiodolisation was defined as the absence of an arterial enhancing lesion, reflecting complete lipiodol uptake, as assessed by dynamic computed tomography (CT) 1 month after treatment. The rate of initial compact lipiodolisation was analysed according to multiplicity and size of tumour, and survival of patients who achieved compact lipiodolisation was compared to that of patients who did not. RESULTS: Of the 490 patients, 409 (83.5%) were in Child-Pugh class A and 81 (16.5%) in class B. The rate of initial compact lipiodolisation in single HCCs was higher than that in multinodular HCCs (33.7% vs. 14.6%, P < 0.001). Among single HCCs, the rate of compact lipiodolisation in tumours ≤5, 5-10 and >10 cm was 46.6%, 13.6%, and 0% respectively. The 1-, 3- and 5-year survival rates of patients with compact uptake were 92.7%, 70.7% and 52.4% compared to 60.8%, 28.0% and 16.9% in patients with noncompact lipiodolisation. Multivariate analysis revealed that Child-Pugh class, alpha-fetoprotein level, tumour node metastasis stage, portal vein thrombosis and initial compact lipiodolisation were independent predictors of survival. CONCLUSIONS: Initial compact lipiodol uptake after transarterial chemoembolisation is associated with improved survival in patients with unresectable hepatocellular carcinoma. Accordingly, initial complete lipiodolisation should be considered a relevant therapeutic target.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfAlimentary Pharmacology and Therapeutics-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleRadiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiology (영상의학)-
dc.contributor.googleauthorD. Y. Kim-
dc.contributor.googleauthorH. J. Ryu-
dc.contributor.googleauthorJ. Y. Choi-
dc.contributor.googleauthorJ. Y. Park-
dc.contributor.googleauthorD. Y. Lee-
dc.contributor.googleauthorB. K. Kim-
dc.contributor.googleauthorS. U. Kim-
dc.contributor.googleauthorS. H. Ahn-
dc.contributor.googleauthorC. Y. Chon-
dc.contributor.googleauthorK.-H. Han-
dc.identifier.doi10.1111/j.1365-2036.2012.05089.x-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA04200-
dc.contributor.localIdA04268-
dc.contributor.localIdA00487-
dc.contributor.localIdA00654-
dc.contributor.localIdA01334-
dc.contributor.localIdA01675-
dc.contributor.localIdA02226-
dc.contributor.localIdA02718-
dc.contributor.localIdA03544-
dc.contributor.localIdA00385-
dc.relation.journalcodeJ00061-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2012.05089.x/abstract-
dc.contributor.alternativeNameChoi, Jin Young-
dc.contributor.alternativeNameKim, Do Young-
dc.contributor.alternativeNameHan, Kwang Hyup-
dc.contributor.alternativeNameKim, Beom Kyung-
dc.contributor.alternativeNameKim, Seung Up-
dc.contributor.alternativeNameRyu, Han Jak-
dc.contributor.alternativeNamePark, Jun Yong-
dc.contributor.alternativeNameAhn, Sang Hoon-
dc.contributor.alternativeNameLee, Do Yun-
dc.contributor.alternativeNameChon, Chae Yoon-
dc.contributor.affiliatedAuthorChoi, Jin Young-
dc.contributor.affiliatedAuthorHan, Kwang Hyup-
dc.contributor.affiliatedAuthorKim, Beom Kyung-
dc.contributor.affiliatedAuthorKim, Seung Up-
dc.contributor.affiliatedAuthorRyu, Han Jak-
dc.contributor.affiliatedAuthorPark, Jun Yong-
dc.contributor.affiliatedAuthorAhn, Sang Hoon-
dc.contributor.affiliatedAuthorLee, Do Yun-
dc.contributor.affiliatedAuthorChon, Chae Yoon-
dc.contributor.affiliatedAuthorKim, Do Young-
dc.citation.volume35-
dc.citation.number11-
dc.citation.startPage1343-
dc.citation.endPage1350-
dc.identifier.bibliographicCitationAlimentary Pharmacology and Therapeutics, Vol.35(11) : 1343-1350, 2012-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.